Chunde Li

Publications
CV
Public outreach and news

Articles

Article: JOURNAL OF CLINICAL ONCOLOGY. 2020;38(5):395-405
Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 Study
Antonarakis ES; Piulats JM; Gross-Goupil M; Goh J; Ojamaa K; Hoimes CJ; Vaishampayan U; Berger R; Sezer A; Alanko T; de Wit R; Li C; Omlin A; Procopio G; Fukasawa S; Tabata K-I; Park SH; Feyerabend S; Drake CG; Wu H; Qiu P; Kim J; Poehlein C; de Bono JS
Article: SPRINGERPLUS. 2016;5(1):1861
Identification of mutations, gene expression changes and fusion transcripts by whole transcriptome RNAseq in docetaxel resistant prostate cancer cells
Ma Y; Miao Y; Peng Z; Sandgren J; De Stahl TD; Huss M; Lennartsson L; Liu Y; Nister M; Nilsson S; Li C
Article: PLOS ONE. 2016;11(1):e0145545
Improving the Prediction of Prostate Cancer Overall Survival by Supplementing Readily Available Clinical Data with Gene Expression Levels of IGFBP3 and F3 in Formalin-Fixed Paraffin Embedded Core Needle Biopsy Material
Peng Z; Andersson K; Lindholm J; Dethlefsen O; Pramana S; Pawitan Y; Nister M; Nilsson S; Li C
Article: PROSTATE CANCER AND PROSTATIC DISEASES. 2014;17(1):81-90
An expression signature at diagnosis to estimate prostate cancer patients' overall survival
Peng Z; Skoog L; Hellborg H; Jonstam G; Wingmo I-L; Hjalm-Eriksson M; Harmenberg U; Cedermark GC; Andersson K; Ahrlund-Richter L; Pramana S; Pawitan Y; Nister M; Nilsson S; Li C
Article: PLOS ONE. 2014;9(10):e109610
Operator Dependent Choice of Prostate Cancer Biopsy Has Limited Impact on a Gene Signature Analysis for the Highly Expressed Genes IGFBP3 and F3 in Prostate Cancer Epithelial Cells
Peng Z; Andersson K; Lindholm J; Bodin I; Pramana S; Pawitan Y; Nister M; Nilsson S; Li C
Article: JOURNAL OF EXPERIMENTAL AND CLINICAL CANCER RESEARCH. 2010;29(1):162
XAF1 expression and regulatory effects of somatostatin on XAF1 in prostate cancer cells
Xing Z; Zhou Z; Yu R; Li S; Li C; Nilsson S; Liu Z
Article: EUROPEAN JOURNAL OF HUMAN GENETICS. 2008;16(12):1521-1525
Influence of MUC1 genetic variation on prostate cancer risk and survival
Strawbridge RJ; Nister M; Brismar K; Li C; Lindstrom S
Article: GROWTH HORMONE AND IGF RESEARCH. 2007;17(5):392-398
GHR exon 3 polymorphism:: Association with type 2 diabetes mellitus and metabolic disorder
Strawbridge RJ; Karvestedt L; Li C; Efendic S; Ostenson CG; Gu HF; Brismar K
Article: CANCER RESEARCH. 2007;67(18):8504-8510
Genomic profiling reveals alternative genetic pathways of prostate tumorigenesis
Lapointe J; Li C; Giacomini CP; Salari K; Huang S; Wang P; Ferrari M; Hernandez-Boussard T; Brooks JD; Pollack JR
Article: MODERN PATHOLOGY. 2007;20(4):467-473
A variant TMPRSS2 isoform and ERG fusion product in prostate cancer with implications for molecular diagnosis
Lapointe J; Kim YH; Miller MA; Li C; Kaygusuz G; van de Rijn M; Huntsman DG; Brooks JD; Pollack JR
Article: CANCER RESEARCH. 2005;65(18):8118-8124
The retinoic acid synthesis gene ALDH1a2 is a candidate tumor suppressor in prostate cancer
Kim H; Lapointe J; Kaygusuz G; Ong DE; Li CD; van de Rijn M; Brooks JD; Pollack JR
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2004;101(3):811-816
Gene expression profiling identifies clinically relevant subtypes of prostate cancer
Lapointe J; Li C; Higgins JP; van de Rijn M; Bair E; Montgomery K; Ferrari M; Egevad L; Rayford W; Bergerheim U; Ekman P; DeMarzo AM; Tibshirani R; Botstein D; Brown PO; Brooks JD; Pollack JR
Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2003;22(5):1003-1007
Mutation analysis of the BRG1 gene in prostate cancer clinical samples
Valdman A; Nordenskjöld A; Fang XL; Naito A; Al-Shukri S; Larsson C; Ekman P; Li CD
Article: INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE. 2003;11(4):529-533
Difference between Swedish and Japanese men in the association between AR CAG repeats and prostate cancer suggesting a susceptibility-modifying locus overlapping the androgen receptor gene
Li CD; Grönberg H; Matsuyama H; Weber G; Nordenskjöld M; Naito K; Bergh A; Bergerheim U; Damber JE; Larsson C; Ekman P
Article: ONCOGENE. 2000;19(11):1392-1399
Combined LOH/CGH analysis proves the existence of interstitial 3p deletions in renal cell carcinoma
Alimov A; Kost-Alimova M; Liu J; Li CD; Bergerheim U; Imreh S; Klein G; Zabarovsky ER
Article: EUROPEAN UROLOGY. 2000;37(3):358-365
Chromosomal numerical aberrations detected by fluorescence in situ hybridization on bladder washings from patients with bladder cancer
Marano A; Pan Y; Li CD; Pagliarulo A; Elmberger G; Tribukait B; Ekman P; Bergerheim U
Article: ANTICANCER RESEARCH. 1999;19(5B):3841-3846
Somatic mutation and homozygous deletion of PTEN/MMAC1 gene at 10q23 in renal cell carcinoma
Alimov A; Li CD; Gizatullin R; Fredriksson V; Sundelin B; Klein G; Zabarovsky E; Bergerheim U
Article: PROSTATE. 1999;39(4):262-268
Links between genetic and environmental factors and prostate cancer risk
Ekman P; Grönberg H; Matsuyama H; Kivineva M; Bergerheim USR; Li CD
Article: GENES CHROMOSOMES AND CANCER. 1999;24(3):175-182
Distinct deleted regions on chromosome segment 16q23-24 associated with metastases in prostate cancer
Li CD; Berx G; Larsson C; Auer G; Aspenblad U; Pan Y; Sundelin B; Ekman P; Nordenskjöld M; van Roy F; Bergerheim USR
Article: PROSTATE. 1998;36(1):31-38
Chromosome 16q24 deletion and decreased E-cadherin expression:: Possible association with metastatic potential in prostate cancer
Pan Y; Matsuyama H; Wang NN; Yoshihiro S; Häggarth L; Li C; Tribukait B; Ekman P; Bergerheim USR
Article: ONCOGENE. 1998;16(4):481-487
Identification of two distinct deleted regions on chromosome 13 in prostate cancer
Li CD; Larsson C; Futreal A; Lancaster J; Phelan C; Aspenblad U; Sundelin B; Liu Y; Ekman P; Auer G; Bergerheim USR
Article: HUMAN MUTATION. 1998;Suppl 1:S31-S33
Germline mutations detected in the von Hippel-Lindau disease tumor suppressor gene by southern blot and direct genomic DNA sequencing
Li CD; Weber G; Ekman P; Lagercrantz J; Norlen BJ; Akerstrom G; Nordenskjold M; Bergerheim USR
Article: CANCER GENETICS. 1996;86(2):95-101
Genotypic and phenotypic characterization of two newly established renal cell carcinoma cell lines
Bergerheim USR; Soderhall M; Zabarovsky E; Franzen B; ManneborgSandlund A; Li CD; Jacobson SH; Auer G; Klein G; Collins VP
Article: CYTOGENETIC AND GENOME RESEARCH. 1996;75(1):17-21
Chromosome imbalances in papillary renal cell carcinoma and first cytogenetic data of familial cases analyzed by comparative genomic hybridization
Bentz M; Bergerheim USR; Li C; Joos S; Werner CA; Baudis M; Gnarra J; Merino MJ; Zbar B; Linehan WM; Lichter P
Show more

All other publications

Corrigendum: SPRINGERPLUS. 2016;5(1):2084
Erratum to: Identification of mutations, gene expression changes and fusion transcripts by whole transcriptome RNAseq in docetaxel resistant prostate cancer cells.
Ma Y; Miao Y; Peng Z; Sandgren J; De Ståhl TD; Huss M; Lennartsson L; Liu Y; Nistér M; Nilsson S; Li C
Thesis / dissertation: 1999
Tracking functional changes in the cancer genome : a molecular genetic analysis of renal and prostatic carcinomas using PCR based techniques by a candidate chromosome and candidate gene approach
Li, Chunde
Published conference paper: BRITISH JOURNAL OF UROLOGY. 1997;79:35-41
Environmental and genetic factors: A possible link with prostate cancer
Ekman P; Pan Y; Li C; Dich J

Employments

Affiliated to Research, Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, 2024-2027

Degrees and Education

Docent, Karolinska Institutet, 2015
Doctor Of Philosophy, Dept of Surgical Science, Karolinska Institutet, 1999

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI